- seekingalpha.com
- Posted On 11 November 2026
Capricor Therapeutics shares rise as FDA decision nears (CAPR:NASDAQ)
Capricor Therapeutics (CAPR) shares rose 4.4% in extended trading Tuesday after the biotechnology company reported a wider third-quarter loss and missed Wall St...
Source:
seekingalpha.com